Center for Scientific Review; Notice of Closed Meetings, 8218-8219 [2024-02265]
Download as PDF
<![CDATA[
8218
Federal Register / Vol. 89, No. 25 / Tuesday, February 6, 2024 / Notices
The survey instrument includes
several changes from the prior 3-year
cycle:
Added a new section, ‘‘Request for
Hearing.’’ The section focuses on how
customers requested a hearing, how
satisfied they were with the method
they used to request a hearing, and
about the clarity of form OMHA–100
(Request for ALJ Hearing or Review of
Dismissal).
Changed ‘‘Hard Copy, internet and
Phone Information’’ section to
‘‘Communications and Web Tools’’
section.
Added a brief statement about when
customers should have received the
‘‘Notice of Nondiscrimination’’
document.
Added two satisfaction questions for
appellants who used the e-Appeal
Portal—one about updates the portal
provides on their appeal and another
about using the portal for uploading
documents electronically.
Changed ‘‘Telephone Hearing’’
section to ‘‘Hearing.’’ The appellant is
asked what type of hearing they had
(telephone or video) and satisfaction
with using that method. If they attended
a telephone hearing, appellants will be
asked whether they were offered the
option of a video hearing; if not, they
will be asked if they would have
participated in a video hearing if
offered.
Data collection instruments and
recruitment materials will be offered in
English and Spanish. The estimated
total number of respondents across all 3
years is 2,400 (800 respondents each FY
for FY 2024, FY 2025, and FY2026). The
estimated total annual burden hours
expected across all years is 600 hours
(200 hours each FY for FY 2024, FY
2025, and FY 2026).
The survey will be conducted
annually, and survey respondents will
consist of Medicare beneficiaries and
non-beneficiaries (i.e., providers,
suppliers) who participated in a hearing
before an OMHA ALJ. OMHA will draw
a representative, nonredundant sample
of appellants whose cases had been
closed in the first 6 months of the
surveyed fiscal year.
ANNUALIZED BURDEN HOUR TABLE
Forms
(if necessary)
Respondents
(if necessary)
Total ...............................................
15/60
15/60
100
100
...............................................................
800
1
....................
200
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Total
burden
hours
1
1
BILLING CODE 4150–46–P
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–23–
122: Research With Activities Related to
Diversity (REWARD).
Date: March 1, 2024.
Time: 9:30 a.m. to 8:00 p.m.
Jkt 262001
Average
burden
per
response
400
400
[FR Doc. 2024–02397 Filed 2–5–24; 8:45 am]
18:15 Feb 05, 2024
Number of
responses per
respondents
Beneficiaries .........................................
Non-Beneficiaries .................................
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
VerDate Sep<11>2014
Number of
respondents
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Bellinger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158,
Bethesda, MD 20892, (301) 827–4446,
bellingerjd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Learning, Memory, Language,
Communication and Related Neuroscience.
Date: March 4–5, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications,
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Eileen Marie Moore, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–8928, eileen.moore@
nih.gov.
Name of Committee: Oncology 1-Basic
Translational Integrated Review Group;
Biochemical and Cellular Oncogenesis Study
Section.
Date: March 4–5, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Cao, M.D., Scientific
Review Officer, Center for Scientific Review,
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 827–5902,
caojn@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology A Integrated Review Group;
Viral Pathogenesis and Immunity Study
Section.
Date: March 4–5, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: Neerja Kaushik-Basu,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, (301)435–
1742, kaushikbasun@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Translational Immuno-oncology
Study Section.
Date: March 4–5, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria Elena CardenasCorona, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20817, 301–867–5309,
maria.cardenas-corona@nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Motor Function, Speech and
Rehabilitation Study Section.
E:\FR\FM\06FEN1.SGM
06FEN1
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 25 / Tuesday, February 6, 2024 / Notices
Date: March 4–5, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stephanie Nagle Emmens,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–6604, nagleemmenssc@
csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Maximizing Investigators’
Research Award—E Study Section.
Date: March 5–6, 2024.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: Vandana Kumari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 496–3290,
vandana.kumari@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Cell Biology, Developmental
Biology, and Bioengineering.
Date: March 5–6, 2024.
Time: 8:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Alexander Gubin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4196,
MSC 7812, Bethesda, MD 20892, 301–435–
2902, gubina@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Cardiovascular and Respiratory Diseases
Study Section.
Date: March 5–6, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mohammed F A
Elfaramawi, M.D., Ph.D., Scientific Review
Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 1007F, Bethesda, MD 20892,
(301) 480–1142, elfaramawimf@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Health
Services Research: Topics in Aging, Cancer,
Maternal and Child Health, and Substance
Abuse.
Date: March 5–6, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
VerDate Sep<11>2014
18:15 Feb 05, 2024
Jkt 262001
Contact Person: Debasmita Patra, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006E,
Bethesda, MD 20892, (301) 827–5187,
debasmita.patra@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Clinical Care and Health
Interventions (Overflow).
Date: March 5, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacinta Bronte-Tinkew,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
MSC 7770, Bethesda, MD 20892, (301) 806–
0009, Jacinta.bronte-tinkew@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Neurodevelopment, Oxidative
Stress, and Synaptic Plasticity Fellowship
Study Section.
Date: March 5–7, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert C Elliott, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5190,
MSC 7846, Bethesda, MD 20892, 301–435–
3009, elliotro@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
Bacterial-Host Interactions Study Section.
Date: March 6–7, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Canopy by Hilton, 940 Rose Avenue,
North Bethesda, MD 20852.
Contact Person: Uma Basavanna, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 827–1398, uma.basavanna@
nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Health Services: Quality and Effectiveness
Study Section.
Date: March 6–7, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Angela D Thrasher, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000J,
Bethesda, MD 20892, (301) 480–6894,
thrasherad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
8219
22–028: The Intersection of Sex and Gender
Influences on Health and Disease.
Date: March 6–7, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Heidi B Friedman, Ph.D.,
Senior Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 907–H,
Bethesda, MD 20892, (301) 379–5632,
hfriedman@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–23–
214: COVID–19 and Brain Health.
Date: March 6, 2024.
Time: 2:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aleksey Gregory
Kazantsev, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5201, Bethesda, MD 20892, (301) 435–
1042, aleksey.kazantsev@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 31, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–02265 Filed 2–5–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\06FEN1.SGM
06FEN1
]]>Agencies
[Federal Register Volume 89, Number 25 (Tuesday, February 6, 2024)]
[Notices]
[Pages 8218-8219]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02265]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-23-122: Research With Activities Related to Diversity
(REWARD).
Date: March 1, 2024.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Bellinger, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, (301)
827-4446, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Learning, Memory, Language, Communication and
Related Neuroscience.
Date: March 4-5, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications,
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Eileen Marie Moore, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-8928,
[email protected].
Name of Committee: Oncology 1-Basic Translational Integrated
Review Group; Biochemical and Cellular Oncogenesis Study Section.
Date: March 4-5, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Cao, M.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 827-5902,
[email protected].
Name of Committee: Infectious Diseases and Immunology A
Integrated Review Group; Viral Pathogenesis and Immunity Study
Section.
Date: March 4-5, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: Neerja Kaushik-Basu, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD
20892, (301)435-1742, [email protected].
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Translational Immuno-oncology Study Section.
Date: March 4-5, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria Elena Cardenas-Corona, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20817, 301-867-5309,
[email protected].
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Motor Function, Speech and Rehabilitation
Study Section.
[[Page 8219]]
Date: March 4-5, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stephanie Nagle Emmens, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-6604,
[email protected].
Name of Committee: Biological Chemistry and Macromolecular
Biophysics Integrated Review Group; Maximizing Investigators'
Research Award--E Study Section.
Date: March 5-6, 2024.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: Vandana Kumari, Ph.D., Scientific Review
Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 496-3290, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Cell Biology, Developmental Biology, and
Bioengineering.
Date: March 5-6, 2024.
Time: 8:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW, Washington, DC 20015.
Contact Person: Alexander Gubin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4196, MSC 7812, Bethesda, MD
20892, 301-435-2902, [email protected].
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Cardiovascular and Respiratory Diseases
Study Section.
Date: March 5-6, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mohammed F A Elfaramawi, M.D., Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007F, Bethesda, MD 20892, (301)
480-1142, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Health Services Research: Topics in Aging, Cancer, Maternal
and Child Health, and Substance Abuse.
Date: March 5-6, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Debasmita Patra, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006E, Bethesda, MD 20892, (301)
827-5187, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Clinical Care and Health Interventions
(Overflow).
Date: March 5, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacinta Bronte-Tinkew, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164, MSC 7770, Bethesda, MD
20892, (301) 806-0009, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Neurodevelopment, Oxidative Stress, and Synaptic
Plasticity Fellowship Study Section.
Date: March 5-7, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert C Elliott, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5190, MSC 7846, Bethesda, MD
20892, 301-435-3009, [email protected].
Name of Committee: Infectious Diseases and Immunology B
Integrated Review Group; Bacterial-Host Interactions Study Section.
Date: March 6-7, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD
20852.
Contact Person: Uma Basavanna, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 827-1398,
[email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Health Services: Quality and Effectiveness
Study Section.
Date: March 6-7, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Angela D Thrasher, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000J, Bethesda, MD 20892, (301)
480-6894, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD-22-028: The Intersection of Sex and Gender Influences
on Health and Disease.
Date: March 6-7, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Heidi B Friedman, Ph.D., Senior Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 907-H, Bethesda, MD 20892, (301)
379-5632, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-23-214: COVID-19 and Brain Health.
Date: March 6, 2024.
Time: 2:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aleksey Gregory Kazantsev, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20892, (301)
435-1042, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 31, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-02265 Filed 2-5-24; 8:45 am]
BILLING CODE 4140-01-P
